LIORESAL INTRATHECAL 0.5MG/ML SOLUTION

Land: Canada

Språk: engelsk

Kilde: Health Canada

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
05-05-2020

Aktiv ingrediens:

BACLOFEN

Tilgjengelig fra:

NOVARTIS PHARMACEUTICALS CANADA INC

ATC-kode:

M03BX01

INN (International Name):

BACLOFEN

Dosering :

0.5MG

Legemiddelform:

SOLUTION

Sammensetning:

BACLOFEN 0.5MG

Administreringsrute:

INTRATHECAL

Enheter i pakken:

20ML

Resept typen:

Prescription

Terapeutisk område:

GABA-DERIVATIVE SKELETAL MUSCLE RELAXANTS

Produkt oppsummering:

Active ingredient group (AIG) number: 0113246005; AHFS:

Autorisasjon status:

CANCELLED POST MARKET

Autorisasjon dato:

2023-08-28

Preparatomtale

                                _ _
_Page 1 of 40_
PRODUCT MONOGRAPH
Pr
LIORESAL
® INTRATHECAL
(baclofen injection)
0.05 mg/mL, 0.5 mg/mL and 2 mg/mL
For intrathecal injection and infusion only
Antispastic Agent
_ _
_ _
_ _
_ _
_ _
_ _
_ _
Novartis Pharmaceuticals Canada Inc.
DATE OF PREPARATION:
385 Bouchard Blvd.
September 13, 1994
Dorval, Quebec H9S 1A9
DATE OF REVISION:
May 5, 2020
Submission Control No: 235751
LIORESAL is a registered trademark.
_ _
_Page 2 of 40_
PRODUCT MONOGRAPH
PR
LIORESAL
® INTRATHECAL
(baclofen injection)
0.05 mg/mL, 0.5 mg/mL and 2 mg/mL
For intrathecal injection and infusion only
THERAPEUTIC CLASSIFICATION
Antispastic Agent
CLINICAL PHARMACOLOGY
The precise mechanisms of action of LIORESAL (baclofen) as an
antispastic agent are not fully
understood. Baclofen inhibits both monosynaptic and polysynaptic
reflex transmission at the
spinal level, possibly by decreasing excitatory neurotransmitter
release from primary afferent
terminals. Actions at supraspinal sites may also contribute to its
clinical effect. Baclofen is an
analogue of the inhibitory neurotransmitter gamma-aminobutyric acid
(GABA), and may exert
its effects by stimulation of the GABA
B
receptor subtype. _ _
Baclofen has been shown to have general Central Nervous System (CNS)
depressant properties
as indicated by the production of sedation with tolerance, somnolence,
ataxia and respiratory and
cardiovascular depression. A dose-dependent inhibitory effect on
erectile function has been
shown in men through GABA
B
receptor stimulation.
In neurological diseases associated with spasm of the skeletal
muscles, LIORESAL Intrathecal
may
have
beneficial
action
on
reflex
muscle
contractions,
painful
spasm,
automatism,
hyperreflexia, trismus and clonus. Neuromuscular transmission is not
affected by baclofen.
Baclofen may also reduce pain associated with spasticity.
_ _
_Page 3 of 40_
PHARMACODYNAMICS OF LIORESAL INTRATHECAL:
INTRATHECAL BOLUS:
The onset of action is generally half an hour to one hour after
administration of an intrathecal
bolus dose. Peak antispast
                                
                                read_full_document
                                
                            

Dokumenter på andre språk

Preparatomtale Preparatomtale fransk 05-05-2020

Søk varsler relatert til dette produktet